INGN News and Press, Inogen Inc From 12/09/21

With the sharpest gain in four months, Inogen (INGN +5.1%) shares have reached a one-month high after Needham upgraded the stock to Buy from Hold, noting an improvement in its supply chain issues. Early November, Inogen (NASDAQ:INGN) management attributed supply chain problems in the semicond...

Inogen, Inc. (INGN) Q3 2021 Earnings Conference Call November 04, 2021, 05:00 PM ET Company Participants Jason Somer - General Counsel Nabil Shabshab - CEO Alison Bauerlein - CFO Conference Call Participants Robert Marcus - JPMorgan Margarate Boeye - William Blair Danielle Antalffy - SVB Leer...

Image source: The Motley Fool. Inogen, inc (NASDAQ: INGN) Q3 2021 Earnings Call Nov 4, 2021 , 5:00 p.m. ET Operator Continue reading For further details see: Inogen, inc (INGN) Q3 2021 Earnings Call Transcript

Inogen (NASDAQ:INGN): Q3 GAAP EPS of $0.53 beats by $0.78. Revenue of $93.1M (+25.3% Y/Y) beats by $6.41M. Press Release Due to the expected supply chain constraints impacting semiconductor chip supply, the Company expects total revenue in the fourth quarter of 2021 to be similar to revenue i...

– Q3 2021 Total Revenue increased 25.3% from the same period in 2020 to $93.1 million – Inogen, Inc. (NASDAQ: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial res...

Inogen, Inc. (NASDAQ: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in Stifel Virtual Healthcare Conference. Inogen’s President ...

Inogen, Inc . (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release third quarter 2021 financial results after market close on Thursday, November 4, 2021. The Company will host a cor...

Inogen, Inc. (NASDAQ: INGN ), (“Inogen” or “the Company”), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that Stanislav Glezer, MD has been appointed to the role of Chief Technol...

Expands Prescriber-Facing Sales Force and Enhances Critical Capabilities with the Goal of Driving Top-Line Growth Inogen, Inc. (NASDAQ: INGN ), (“Inogen” or “the Company”), a medical technology company offering innovative respiratory produ...

Gainers: Gevo (NASDAQ:GEVO) +35%. American Virtual Cloud Technologies (NASDAQ:AVCT) +33%. Rocket Lab (NASDAQ:RKLB) +32%. Torrid (NYSE:CURV) +30%. Montauk (NASDAQ:MNTK) +25%. Impel (NASDAQ:IMPL) +22%. Gold Royalty (NYSE:GROY) +22%. ProQR (NASDAQ:PRQR) +21%. Hyzon (NASDAQ:HYZN) +21%. Rockley (N...